Zachi Berger

Append Medical Ltd. is a medical device company based in Israel. The Israeli company is developing the Appligator™, a device designed to completely close the left atrial appendage (LAA) in a transcatheter procedure without requiring any metal implants. This tool is designed to reduce stroke risk in AF patients by excluding the LAA to prevent blood clot leakage with a minimally invasive transseptal intervention leaving no implant behind. The company was founded in 2018 by Dr. Zachi Berger and is a portfolio company of the MedX Xelerator, an Israeli medical device incubator. The company was founded by Dr. Zachi Berger and has been led by CEO Nadav Agian since 2022.

QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel.